Browsing Category
Featured Articles
FDA Grants Orphan Drug Designation to Kadmon’s KD025 for the Treatment of cGVHD
Kadmon Holdings announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KD025, the Company’s Rho-associated coiled-coil kinase (ROCK)…
Read More...
Read More...
Smithers Avanza Toxicology Services Adds Peter Capozziello as Director, Business Development
Smithers Avanza, a boutique contract research organization (CRO) supporting the pharmaceutical and chemical industries, named Peter Capozziello its new Director, Business Development.…
Read More...
Read More...
Avara Pharmaceutical sign agreement to acquire Reims from AstraZeneca in France
Avara Pharmaceutical Services has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility. "This key acquisition is…
Read More...
Read More...
